These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 15233569)

  • 1. [New antiplatelet agents (platelet receptor blockers): has aspirin come out of place?].
    Tsakiris DA
    Praxis (Bern 1994); 2004 Jun; 93(23):1003-5. PubMed ID: 15233569
    [No Abstract]   [Full Text] [Related]  

  • 2. [Treatment of ischemic heart disease with the platelet aggregation inhibitor clopidogrel].
    Helø OH; Madsen JK; Kastrup J
    Ugeskr Laeger; 2004 Apr; 166(18):1659-62. PubMed ID: 15174400
    [No Abstract]   [Full Text] [Related]  

  • 3. Guidelines for the management of antiplatelet therapy in patients with coronary stents undergoing non-cardiac surgery.
    Cardiac Society of Australia and New Zealand
    Heart Lung Circ; 2010 Jan; 19(1):2-10. PubMed ID: 20045378
    [No Abstract]   [Full Text] [Related]  

  • 4. [Two platelet inhibitors after acute coronary syndrome. Many colleagues are not aware of this].
    MMW Fortschr Med; 2002 Mar; 144(13):50. PubMed ID: 12008695
    [No Abstract]   [Full Text] [Related]  

  • 5. Clopidogrel with aspirin is the optimal antiplatelet regimen for intracoronary stenting.
    Steinhubl SR; Topol EJ
    J Thromb Thrombolysis; 1999 Jun; 7(3):227-31. PubMed ID: 10373712
    [No Abstract]   [Full Text] [Related]  

  • 6. [Pharmacology of ticlopidine and clopidogrel in comparison with acetylsalicylic acid].
    Weber AA; Schrör K
    Internist (Berl); 1997 Nov; 38(11):1115-20; discussion 1120. PubMed ID: 9453968
    [No Abstract]   [Full Text] [Related]  

  • 7. Dual antiplatelet therapy for coronary stenting: a clear path for a research agenda.
    Leopold JA; Antman EM
    Circulation; 2005 Mar; 111(9):1097-9. PubMed ID: 15753225
    [No Abstract]   [Full Text] [Related]  

  • 8. Clopidogrel plus aspirin for stroke prevention.
    Alberts MJ; Easton JD
    Stroke; 2002 Nov; 33(11):2546-7; author reply 2546-7. PubMed ID: 12411639
    [No Abstract]   [Full Text] [Related]  

  • 9. Combination therapy with clopidogrel and aspirin: can the CURE results be extrapolated to cerebrovascula patients?
    Albers GW; Amarenco P
    Stroke; 2001 Dec; 32(12):2948-9. PubMed ID: 11740003
    [No Abstract]   [Full Text] [Related]  

  • 10. New modalities and aspects of antiplatelet therapy for stroke prevention.
    Uchiyama S; Nakamura T; Yamazaki M; Kimura Y; Iwata M
    Cerebrovasc Dis; 2006; 21 Suppl 1():7-16. PubMed ID: 16479097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiplatelet drugs for patients at high cardiovascular risk. Aspirin generally remains the best choice.
    Prescrire Int; 2009 Dec; 18(104):272-3. PubMed ID: 20027714
    [No Abstract]   [Full Text] [Related]  

  • 12. Aspirin and ticlopidine after routine coronary stenting: the gold standard as of 1999.
    McCullough PA; Marks KR
    J Thromb Thrombolysis; 1999 Jun; 7(3):233-9. PubMed ID: 10373716
    [No Abstract]   [Full Text] [Related]  

  • 13. Enhanced platelet inhibition by adjunctive cilostazol to dual antiplatelet therapy after drug-eluting stent implantation for complex lesions.
    Jeong YH; Park Y; Kim IS; Yun SE; Kang MK; Hwang SJ; Kwak CH; Hwang JY
    Thromb Haemost; 2010 Dec; 104(6):1286-9. PubMed ID: 20838742
    [No Abstract]   [Full Text] [Related]  

  • 14. New antiplatelet agents: ticlopidine and clopidogrel. Antiplatelet therapy but at what cost?
    Black C; Paterson KR
    Adverse Drug React Toxicol Rev; 2001 Dec; 20(4):277-303. PubMed ID: 11770173
    [No Abstract]   [Full Text] [Related]  

  • 15. Clopidogrel: new indication. In combination with aspirin: marginal additional benefits.
    Prescrire Int; 2007 Aug; 16(90):146. PubMed ID: 17724837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thrombotic and bleeding events after coronary stenting according to clopidogrel and aspirin platelet reactivity: VerifyNow French Registry (VERIFRENCHY).
    Rangé G; Yayehd K; Belle L; Thuaire C; Richard P; Cazaux P; Barbou F; Köning R; Chassaing S; Teiger E; Berthier R; Decomis MP; Claudel JP; Delarche N; Brunel P; De Poli F; Dupouy P; Beygui F; Albert F; Collet JP; Montalescot G;
    Arch Cardiovasc Dis; 2014 Apr; 107(4):225-35. PubMed ID: 24794216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative effectiveness review of antiplatelet agents in peripheral artery disease.
    Schmit K; Dolor RJ; Jones WS; Vemulapalli S; Hasselblad V; Subherwal S; Heidenfelder B; Patel MR
    J Am Heart Assoc; 2014 Dec; 3(6):e001330. PubMed ID: 25477329
    [No Abstract]   [Full Text] [Related]  

  • 18. [Prevention of GI bleeding due to antiplatelet agents: a labyrinth!].
    Bretagne JF
    Presse Med; 2009 Dec; 38(12):1722-6. PubMed ID: 19914029
    [No Abstract]   [Full Text] [Related]  

  • 19. Safety and tolerability of antiplatelet therapies for the secondary prevention of atherothrombotic disease.
    Spinler SA
    Pharmacotherapy; 2009 Jul; 29(7):812-21. PubMed ID: 19558255
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination antiplatelet therapy in patients with peripheral arterial disease: is the best therapy aspirin, clopidogrel, or both?
    Mohler ER
    Catheter Cardiovasc Interv; 2009 Jul; 74 Suppl 1():S1-6. PubMed ID: 19213065
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.